Annual Short Term Debt
$17.29 M
+$1.66 M+10.64%
December 31, 2024
Summary
- As of March 8, 2025, CRSP annual short term debt is $17.29 million, with the most recent change of +$1.66 million (+10.64%) on December 31, 2024.
- During the last 3 years, CRSP annual short term debt has risen by +$5.13 million (+42.19%).
- CRSP annual short term debt is now at all-time high.
Performance
CRSP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$17.29 M
+$405.00 K+2.40%
December 31, 2024
Summary
- As of March 8, 2025, CRSP quarterly short term debt is $17.29 million, with the most recent change of +$405.00 thousand (+2.40%) on December 31, 2024.
- Over the past year, CRSP quarterly short term debt has increased by +$837.00 thousand (+5.09%).
- CRSP quarterly short term debt is now at all-time high.
Performance
CRSP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
CRSP Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +10.6% | +5.1% |
3 y3 years | +42.2% | +5.1% |
5 y5 years | +103.7% | +5.1% |
CRSP Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +42.2% | at high | +109.1% |
5 y | 5-year | at high | +103.7% | at high | +109.1% |
alltime | all time | at high | -100.0% | at high | -100.0% |
CRISPR Therapeutics AG Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $17.29 M(+10.6%) | $17.29 M(+2.4%) |
Sep 2024 | - | $16.88 M(+2.6%) |
Jun 2024 | - | $16.45 M(+2.9%) |
Mar 2024 | - | $15.99 M(+2.3%) |
Dec 2023 | $15.63 M(-1.4%) | $15.63 M(+4.2%) |
Sep 2023 | - | $15.00 M(+1.1%) |
Jun 2023 | - | $14.83 M(-5.6%) |
Mar 2023 | - | $15.72 M(-0.8%) |
Dec 2022 | $15.84 M(+30.3%) | $15.84 M(+40.7%) |
Sep 2022 | - | $11.26 M(+36.2%) |
Jun 2022 | - | $8.27 M(-25.4%) |
Mar 2022 | - | $11.08 M(-8.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $12.16 M(+7.0%) | $12.16 M(-3.8%) |
Sep 2021 | - | $12.64 M(-20.4%) |
Jun 2021 | - | $15.88 M(+31.6%) |
Mar 2021 | - | $12.06 M(+6.2%) |
Dec 2020 | $11.36 M(+33.8%) | $11.36 M(+6.8%) |
Sep 2020 | - | $10.64 M(+7.4%) |
Jun 2020 | - | $9.91 M(+10.0%) |
Mar 2020 | - | $9.01 M(+6.1%) |
Dec 2019 | $8.49 M(>+9900.0%) | $8.49 M(+76.7%) |
Sep 2019 | - | $4.80 M(-1.5%) |
Jun 2019 | - | $4.88 M(-0.4%) |
Mar 2019 | - | $4.90 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is CRISPR Therapeutics AG annual short term debt?
- What is the all time high annual short term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual short term debt year-on-year change?
- What is CRISPR Therapeutics AG quarterly short term debt?
- What is the all time high quarterly short term debt for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly short term debt year-on-year change?
What is CRISPR Therapeutics AG annual short term debt?
The current annual short term debt of CRSP is $17.29 M
What is the all time high annual short term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual short term debt is $17.29 M
What is CRISPR Therapeutics AG annual short term debt year-on-year change?
Over the past year, CRSP annual short term debt has changed by +$1.66 M (+10.64%)
What is CRISPR Therapeutics AG quarterly short term debt?
The current quarterly short term debt of CRSP is $17.29 M
What is the all time high quarterly short term debt for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly short term debt is $17.29 M
What is CRISPR Therapeutics AG quarterly short term debt year-on-year change?
Over the past year, CRSP quarterly short term debt has changed by +$837.00 K (+5.09%)